Stay updated on Nivolumab and Plinabulin in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Plinabulin in NSCLC Clinical Trial page.

Latest updates to the Nivolumab and Plinabulin in NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedPage revision updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange Detected- Revision label updated from v3.4.0 to v3.4.1.SummaryDifference0.1%

- Check27 days agoChange DetectedAdded a glossary section and updated metadata labels, including 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', while older labels such as 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' were removed or adjusted. These changes do not affect the study details, eligibility criteria, or primary outcomes — To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision note updated from v3.3.3 to v3.3.4; no substantive study information appears to have changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a new Locations section showing California as a location (UC San Diego Moores Cancer Center). Removed the California Locations label and the HHS Vulnerability Disclosure, and updated the revision from v3.3.2 to v3.3.3.SummaryDifference0.2%

- Check92 days agoChange DetectedThe site revision was updated to v3.3.2 and v3.2.0 was removed; this is a minor metadata update that does not affect the study details or trial information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nivolumab and Plinabulin in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Plinabulin in NSCLC Clinical Trial page.